Tag: Medical Prices

What’s behind health insurance premiums?

With recent discussions surrounding insurance premiums, it’s important to acknowledge an important fact: Premiums track directly with the underlying cost of care. Continue reading

Posted in: Health Care Costs

Striking down weak patents protects patients

In some cases, explosive drug prices are the result of drugmakers’ patent schemes that financially distress consumers and limit their treatment options. That is why a recent proposal to exempt pharmaceutical companies from a key consumer protection would leave families across the country even more hostage to egregious pharmaceutical prices. Continue reading

Posted in: AHIP Letters, Cost Alert

New Data Brief on Hospital Consolidation and Premiums

The growing body of evidence that hospital consolidation and higher premiums go hand-in-hand has yet another entry. A new AHIP data brief finds that as hospital consolidation increases, so too do premiums. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Hill Briefing Examines the Truth About Premiums

Influential factors that go into premiums took center stage this afternoon at a Capitol Hill briefing hosted by centrist think tank Third Way. The panelists all emphasized the fact that proposed premiums vary greatly; and therefore, it’s crucial to consider the full picture when looking at changes in premiums. Continue reading

Posted in: Cost Alert, On The Hill

Studies, experts agree: Provider consolidation drives up the cost of care

Here’s where it’s important to understand that insurance premiums track the underlying cost of medical care, like the cost of doctor’s visits, hospital stays, and prescription medications. So as the costs of medical care increase, so do premiums. One explanation for increases in hospital prices is consolidation among hospitals and other providers. Continue reading

Posted in: Cost Alert

Nearly $1 trillion in the next 5 years

Global prescription drug sales will grow 4.8 percent a year until reaching $987 billion by 2020, according to a new report from EvaluatePharma. Other findings from the report upend the concept that that research and development costs are driving high prescription drug prices. Continue reading

Posted in: Health Care Costs, Uncategorized

AHIP Briefing: Focus on the Price

Several stakeholders gathered in Washington, D.C., this morning for a panel discussion titled “Cost of Innovation: How the Future Drug Pipeline Will Impact Patient Access, Affordability.” Continue reading

Posted in: Health Care Costs

Health Affairs Examines Exceptionally High Hospital Prices

Hospitals are charging exorbitant prices for services, and those markups continue to make health care coverage more expensive for everyone, according to a study published Monday in the journal Health Affairs. Continue reading

Posted in: Cost Alert

CHART OF THE DAY: Cost of cancer drugs vs. oncology services

This week the Centers for Medicare and Medicaid Services released data that shows spending on cancer drugs in 2013 was more than twice as high as spending on other oncology services, CQ Roll Call reported. The numbers also drive home the unfortunate fact that sky’s-the-limit prices put lifesaving cancer medicines further and further out of reach for those who need them. Continue reading

Posted in: Cost Alert

Too Expensive

While drug manufacturers turn a blind eye to the fact that they charge some of the highest prices in the world, patients are paying attention – and they’re not happy about it. Continue reading

Posted in: Health Care Costs, Uncategorized